UMeWorld Positions DAGola™ for Strong Q4 Revenue Surge with U.S. E-Commerce and China Market Expansion
UMeWorld (OTC:UMEWF) announced major commercial expansion plans for DAGola™, its clinically validated cooking oil product. The company has secured distribution on Walmart Marketplace and Amazon, reaching approximately 80% of U.S. online grocery shoppers.
DAGola™, formulated with advanced enzymatic technology, has demonstrated clinical benefits including reducing triglycerides by up to 80% and lowering uric acid levels. The company plans to launch in China's $25 billion edible oil market by September 2025, while also targeting expansion into Europe and Japan.
The company is implementing a micro-influencer marketing strategy and aims to secure mass-market retail presence in the U.S., expecting significant revenue contribution in Q4 2025.
UMeWorld (OTC:UMEWF) ha annunciato importanti piani di espansione commerciale per DAGola™, il suo prodotto di olio da cucina clinicamente validato. L'azienda ha ottenuto la distribuzione su Walmart Marketplace e Amazon, raggiungendo circa l'80% degli acquirenti online di generi alimentari negli Stati Uniti.
DAGola™, formulato con una tecnologia enzimatica avanzata, ha dimostrato benefici clinici tra cui la riduzione dei trigliceridi fino all'80% e l'abbassamento dei livelli di acido urico. L'azienda prevede di entrare nel mercato cinese dell'olio commestibile da 25 miliardi di dollari entro settembre 2025, puntando anche all'espansione in Europa e Giappone.
La società sta implementando una strategia di marketing con micro-influencer e mira a ottenere una presenza nel mercato retail di massa negli Stati Uniti, prevedendo un contributo significativo ai ricavi nel quarto trimestre del 2025.
UMeWorld (OTC:UMEWF) anunció importantes planes de expansión comercial para DAGola™, su producto de aceite de cocina clínicamente validado. La compañía ha asegurado distribución en Walmart Marketplace y Amazon, alcanzando aproximadamente al 80% de los compradores de comestibles en línea en EE.UU.
DAGola™, formulado con tecnología enzimática avanzada, ha demostrado beneficios clínicos que incluyen la reducción de triglicéridos hasta en un 80% y la disminución de los niveles de ácido úrico. La empresa planea ingresar al mercado chino de aceite comestible de 25 mil millones de dólares para septiembre de 2025, además de buscar expansión en Europa y Japón.
La compañía está implementando una estrategia de marketing con microinfluencers y apunta a asegurar presencia en el mercado minorista masivo en EE.UU., esperando una contribución significativa en ingresos para el cuarto trimestre de 2025.
UMeWorld (OTC:UMEWF)는 임상적으로 검증된 조리용 오일 제품인 DAGola™의 대규모 상업 확장 계획을 발표했습니다. 회사는 Walmart Marketplace와 Amazon에서 유통을 확보하여 미국 온라인 식료품 쇼핑객의 약 80%에 도달하고 있습니다.
첨단 효소 기술로 제조된 DAGola™는 중성지방을 최대 80%까지 감소시키고 요산 수치를 낮추는 등 임상적 이점을 입증했습니다. 회사는 2025년 9월까지 중국의 250억 달러 식용유 시장에 진출할 계획이며, 유럽과 일본으로의 확장도 목표로 하고 있습니다.
회사는 마이크로 인플루언서 마케팅 전략을 시행 중이며 미국 내 대중 시장 소매 진출을 목표로 하여 2025년 4분기에 상당한 매출 기여를 기대하고 있습니다.
UMeWorld (OTC:UMEWF) a annoncé d'importants plans d'expansion commerciale pour DAGola™, son produit d'huile de cuisson cliniquement validé. L'entreprise a sécurisé sa distribution sur Walmart Marketplace et Amazon, atteignant environ 80 % des acheteurs d'épicerie en ligne aux États-Unis.
DAGola™, formulé avec une technologie enzymatique avancée, a démontré des bénéfices cliniques, notamment une réduction des triglycérides jusqu'à 80 % et une diminution des niveaux d'acide urique. La société prévoit de lancer son produit sur le marché chinois de l'huile comestible de 25 milliards de dollars d'ici septembre 2025, tout en visant une expansion en Europe et au Japon.
L'entreprise met en œuvre une stratégie de marketing avec des micro-influenceurs et vise à obtenir une présence dans la grande distribution aux États-Unis, s'attendant à une contribution significative aux revenus au quatrième trimestre 2025.
UMeWorld (OTC:UMEWF) kündigte umfangreiche kommerzielle Expansionspläne für DAGola™ an, sein klinisch validiertes Kochölprodukt. Das Unternehmen hat den Vertrieb auf Walmart Marketplace und Amazon gesichert und erreicht damit etwa 80 % der Online-Lebensmitteleinkäufer in den USA.
DAGola™, formuliert mit fortschrittlicher enzymatischer Technologie, hat klinische Vorteile gezeigt, darunter eine Reduzierung der Triglyzeride um bis zu 80 % und die Senkung der Harnsäurespiegel. Das Unternehmen plant, bis September 2025 in den chinesischen 25-Milliarden-Dollar-essbaren Ölmarkt einzutreten und strebt gleichzeitig eine Expansion nach Europa und Japan an.
Das Unternehmen setzt eine Mikro-Influencer-Marketingstrategie um und zielt darauf ab, eine Präsenz im Massenmarkt-Einzelhandel in den USA zu sichern, wobei im vierten Quartal 2025 ein bedeutender Umsatzbeitrag erwartet wird.
- Secured distribution on Walmart Marketplace and Amazon, reaching 80% of U.S. online grocery shoppers
- Planned entry into China's $25 billion edible oil market by September 2025
- Clinical studies show DAGola reduces triglycerides by up to 80%
- Strategic expansion planned for Europe and Japan markets
- Product differentiation through clinical validation and health benefits
- Success depends on pending production capacity for China market
- Still needs to secure physical retail presence in U.S. mass-market chains
- Relies on new micro-influencer marketing program for brand awareness
MIAMI, July 22, 2025 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC:UMEWF) is pleased to provide a significant commercial update on the expansion of its flagship product, DAGola™, a clinically validated cooking oil formulated using advanced enzymatic technology to produce high-purity diacylglycerol (DAG).
DAGola™ is designed to meet the growing global demand for healthier, functional cooking oils. Unlike conventional oils, DAGola™ is scientifically formulated to support fat metabolism and is clinically proven to reduce triglycerides and lower uric acid levels - two critical markers associated with metabolic syndrome, obesity, and gout. These differentiators make DAGola™ a compelling choice for today’s health-conscious consumers seeking both culinary performance and metabolic support.
DAGola™ is now available on both Walmart Marketplace and Amazon, securing access to the two largest e-commerce grocery platforms in the United States. This milestone gives the brand exposure to approximately
With these key online channels secured, the Company is launching a targeted micro-influencer marketing program to build brand awareness, educate consumers, and drive product trial. Looking ahead, the next strategic objective in the U.S. market is to secure shelf space in mass-market retail chains, including national supermarkets, club stores, and specialty health retailers.
In China, UMeWorld is actively collaborating with several leading national distributors to launch DAGola™ across both online and offline retail channels as early as September, pending production capacity. This expansion provides immediate access to China’s
These commercial achievements are underpinned by DAGola™’s strong scientific validation. Clinical studies have demonstrated the oil’s ability to reduce postprandial triglyceride formation by up to
With U.S. e-commerce distribution firmly in place, influencer-led marketing initiatives underway, and China’s national rollout on track, UMeWorld is well-positioned to execute its 2025 commercial roadmap. Management expects these developments to significantly contribute to top-line growth and strengthen global brand equity over the coming quarters.
Beyond these core markets, UMeWorld is actively pursuing international expansion opportunities. Europe and Japan are near-term priorities, where the Company plans to leverage strategic partnerships and localized marketing initiatives to introduce DAGola™ to a broader base of health-conscious consumers. These efforts aim to capitalize on the growing global appetite for science-backed, functional nutrition while reinforcing UMeWorld’s position as a global innovator in next-generation cooking oils.
About UMeWorld
UMeWorld is redefining the cooking oil industry through science and innovation. Our flagship product, DAGola™, contains up to
About DAGola Inc.
DAGola Inc. is the U.S. branch of UMeWorld Limited. It focuses on selling innovative food products in North America. To learn more about DAGola Inc., visit www.dagolaoil.com.
Forward-Looking Statements
This press release may contain forward-looking statements, about UMeWorld's expectations, beliefs or intentions regarding, among other things, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, UMeWorld or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as "believe," "expect," "intend," "plan," "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by UMeWorld with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of UMeWorld's authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause UMeWorld's actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause UMeWorld's actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements, including, but not limited to, the factors summarized in UMeWorld's filings with the SEC. In addition, UMeWorld operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. UMeWorld does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise. Please see the risk factors associated with an investment in our securities which are included in our Annual Report on Form 20-F and other periodic and current reports filed with the Securities and Exchange Commission.
CONTACT: Contact: Michael Lee CEO, UMeWorld Limited Email: info@umeworld.com
FAQ
What are the main health benefits of UMeWorld's DAGola cooking oil?
Where can consumers purchase DAGola cooking oil in the United States?
When will UMeWorld (UMEWF) launch DAGola in the Chinese market?
What is UMeWorld's expansion strategy for DAGola in 2025?
How does DAGola differ from conventional cooking oils?
